LANDSTEINER SCIENTIFIC, S.A. de C.V. Patent applications |
Patent application number | Title | Published |
20150342968 | STABLE PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS - This invention provides pharmaceutical compositions which increase the bioavailability of risedronate sodium and provides vitamin D3 with greater stability; these compositions are useful in the inhibition of bone resorption. | 12-03-2015 |
20150342921 | METFORMIN-ORLISTAT COMPOSITIONS - This invention provides a combination of a hypoglycemic, metformin, and an irreversible intestinal gastric and pancreatic lipase inhibitor, Orlistat, for a better control of obesity than with the monotherapy used with each of them; this composition provides “low” doses of both drugs to minimize secondary effects and to make use of the synergic effect of both compounds. | 12-03-2015 |
20150190399 | NEW DIFFERENTIAL-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING THREE ACTIVE PRINCIPLES - This invention relates to a differential release formulation containing an angiotensin-II receptor antagonist, a calcium channel blocker and a diuretic, wherein the said pharmaceutical composition allows the sequential administration of the active principles in a single dose based on the treatment needs. | 07-09-2015 |
20110039804 | Composition of Risedronate and Vitamin D3 - The present invention is focused on compositions that contain risedronate and vitamin D as active ingredients. This dose combines the pharmaceutical properties of risedronate, which avoids bone degradation, and those from vitamin D, which fixates calcium to the bone, which are used for treating postmenopausal osteoporosis. | 02-17-2011 |